4 November 2021PatentsAlex Baldwin

Hirshfeld grants first USPTO director review after Arthrex

The acting director of the US Patent and Trademark Office Drew Hirshfeld has agreed for the first time to review a final written decision from the Patent Trial and Appeal Board (PTAB) after being given oversight over the board’s rulings in the Supreme Court’s Arthrex decision.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

Fed Circ confirms Hirshfeld’s authority in Arthrex

30 May 2022 The Federal Circuit has ruled that the interim commissioner of the United States Patent and Trademark Office had decision-making powers in the ongoing Arthrex case.

Patents

Hirshfeld defends IPR review authority under Arthrex

3 February 2022 The acting director of the US Patent and Trademark Office Andrew Hirshfeld has defended his right to review final Patent Trial and Appeal Board decisions under Arthrex.

Influential Women in IP

'Sluggish' growth in women inventor numbers: USPTO

13 February 2019 Women inventors still make up just 12% of all patent inventors in the US, according to the US Patent and Trademark Office.